| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4165095 | The Journal of Pediatrics | 2014 | 6 Pages |
Abstract
Neonatal caffeine therapy for apnea of prematurity reduces the rate of DCD at 5Â years of age. As more children have DCD than have cerebral palsy, this is an important additional benefit from neonatal caffeine treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Lex W. MD, Barbara MD, MSc, Peter J. PhD, Peter G. MD, Diane MD, Ruth E. PhD, Karel MB BCh BAO, Koravangattu MD, Eric MD, PhD, Robin MSc, Caffeine for Apnea of Prematurity Trial investigators Caffeine for Apnea of Prematurity Trial investigators,